A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway - Cheraghchi-Bashi, A; Parker, CA; Curry, E; Salazar, J-F; Gungor, H; Saleem, A; Cunnea, P; Rama, N; Salinas, C; Mills, GB; Morris, SR; Kumar, R; et al. (Oncotarget, 2015)